Evaluation of the efficacy and safety of a stent covered with biosynthetic cellulose in a rabbit iliac artery model

Journal of Invasive Cardiology

Volumn 21, Issue 8, 2009, Pages 392-396

  Bueno, Ronaldo R L ^a   Tanguay, Jean Françcois ^a   Brito Jr , Fabio S ^a   Guerios, Enio E ^a   Tarastchuk, Josée C ^a   Sanches, Pablo A ^a   Andrade, Paulo M ^a   Rossi, Paulo F ^a   Bueno, Felipe L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHETIC CELLULOSE; CELLULOSE; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; BARE METAL STENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY STENT; EVALUATION; ILIAC ARTERY; IMPLANTATION; MORPHOMETRICS; NONHUMAN; RABBIT; RESTENOSIS; SAFETY; STENT THROMBOSIS;

ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ANIMALS; CELLULOSE; COATED MATERIALS, BIOCOMPATIBLE; CONSTRICTION, PATHOLOGIC; ILIAC ARTERY; INCIDENCE; MODELS, ANIMAL; RABBITS; REGIONAL BLOOD FLOW; RISK FACTORS; STENTS; THROMBOSIS; TUNICA INTIMA;

EID: 69249148747     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. De Paola DQ, Souza MGPP. Película celulósica: Novo curativo biológico para melhoria do leito receptor de enxertia cutânea. Rev Bras Cir 1987;77:135-138.
2. Novaes Jr AB, Novaes AB. Implants placed into extraction sockets in association with membrane therapy (Gengiflex) and porous hidroxiopaite. Int J Oral Max Iplts 1992;7:536-540.
3. Mello LR, Feltrin LT, Fontes PTL, Ferraz, FAP. Duraplasty with biosynthetic cellulose: An experimental study. J Neurosurg 1997;86:143-150.
4. Klemm D, Schumann D, Udhardt U, Marsch S. Bacterial synthetized cellulose - Artificial blood vessels for microsurgery. Prog Polym Sci 2001;26:1561-1603. (Pubitemid 33090643)
5. Helenius G, Bäckdahl H, Bodin A, et al. In vivo biocompatibility of bacterial cellulose. J Biomed Mater Res 2006;76A:431-438.
6. Charpentier PA, Maguire A, Wan W. Surface modification of polyester to produce a bacterial cellulose-based vascular prosthetic device. Appl Surf Sci 2006;252:6360-6367. (Pubitemid 44093086)
7. Märtson M, Viljanto J, Hurmer T, et al. Is cellulose sponge degradable or stable as implantation material? An in vivo subcutaneous study in the rat. Biomaterials 1999;20:1989-1995. (Pubitemid 29447620)
8. Macedo NL, Matuda F, Macedo LG, et al. Evaluation of two membranes in guided bone tissue regeneration: Histological study in rabbits. Braz J Oral Sci 2004;3:395-400.
9. Novaes AB Jr, Novaes AB. Guided tissue regeneration versus hemisection in the treatment of furcation lesion. A clinical analysis. Braz Dent J 1993;3:99-102.
10. Watanabe K, Eto Y, Takano S, et al. A new bacterial cellulose substrate for mammalian cell culture. Cytotechnology 1993;13:107-114.
11. Czaja WK, Young DJ, Kawecki M, Brown RM Jr. The future prospects of microbial cellulose in biomedical applications. Biomacromolecules 2007;8:1-12. (Pubitemid 46140466)
12. Stefanadis C, Toutouzas K, Vlachopoulos C, et al. Autologous vein graft-coated stent for treatment of coronary artery disease. Cathet Cardiovasc Diagn 1996;38:159-170. (Pubitemid 126479811)
13. McKenna CJ, Camrud AR, Sangiorgi G, et al. Fibrin-film stenting in a porcine coronary injury model: Efficacy and safety compared with uncoated stent. J Am Coll Cardiol 1998;31:1434-1438. (Pubitemid 28219141)
14. Holmes DR, Camrud AR, Jorgenson MA, et al. Polymeric stenting in the porcine coronary artery model: Differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents. J Am Coll Cardiol 1994;24:535-1531
15. Palmaz JC. Review of polymeric graft materials for endovascular applications. J Vasc Interv Radiol 1998;9:7-13. (Pubitemid 28049685)
16. Jones DWJ. Crystalline modifications of cellulose. Part V. A cristalographic study of ordered molecular arrangements. J Polym Sci 1960;42:173-188.
17. Woodcock S, Sarko A. Packing analysis of carbohydrates and polysaccharides.11.molecular and crystal structure of native ramie cellulose. Macromolecules 1980;13:1183-1187.
18. O'Sullivan AC. Cellulose: The structure slowly unraves. Cellulose 1997;4:173-207.
19. Reidy MA. Endothelial regeneration VII. Interaction of smooth muscle cells with endothelial regrowth. Lab Invest 1988;59:36-43. (Pubitemid 18181945)
20. Bauters C, Labalache J, MacFadden E, et al. Relation of coronary angioscopic findings at coronary angioplasty to angiographic restenosis. Circulation 1995;92:2473-2479.
21. Preisack MB, Karsch KR. The paradigm of restenosis following percutaneous transluminal coronary angioplasty. Eur Heart J 1993;14(Suppl I):187-192. (Pubitemid 23362616)
22. Wilesky RL, March KL, Gradus-Pizio I, et al. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation 1995;92:2995-3005.
23. Schwartz RS, Murphy JG, Edwards WD, et al. Restenosis after balloon angioplasty, a practical proliferative model in porcine coronary arteries. Circulation 1990;82:2190-2200.
24. Scott NA, Cipolla GD, Ross CE, et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury in porcine coronary arteries. Circulation 1996;93:2178-2187.
25. Strauss BH, Chisholm RJ, Keely FW, et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Cir Res 1994;75:650-658.
26. Macleod DC, Stauss BH, de Jong M, et al. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenosis lesions. J Am Coll Cardiol 1994;23:59-65.
27. Seeger JM, Ingegno MD, Bigatan E, et al. Hydrophilic surface modification of metallic endoluminal stents. J Vasc Surg 1995;22:327-336.
28. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;91:2995-3001.
29. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20:1284-1293.
30. McKenna CJ, Burke S, Opgenroth TJ, et al. Selective ET-A receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model. Circulation 1998;97:2551-2556. (Pubitemid 28294502)
31. Kipshidze N, Dangas G, Tsapenko M, et al. Role of the endothelium in modulating neointimal formation. J Am Coll Cardiol 2004;44:733-739.
32. Sokolnicki AM, Fisher RJ, Harrah TP, Kaplan D. Permeability of bacterial cellulose membranes. J Membr Sci 2006;272:15-27.
33. Hardhammar PA, van Beusekom HMM, Emanuelsson H, et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stent in normal porcine coronary arteries. Circulation 1996;93:423-430. (Pubitemid 26043600)
34. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: Early outcome of the BENESTENT II pilot study. Circulation 1996;93:412-422. (Pubitemid 26043599)
35. Asahara T, Tsurumi Y, Kearney M, et al. Accelerated restitution of endothelial integrity and endothelium dependent function following rtVEGF165 gene transfer. Circulation 1996;94:3291-11302 (Pubitemid 26427501)
36. van Belle E, Tio FO, Couffinhal T, et al. Stent endothelialization; time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 1997;95:438-448. (Pubitemid 27056212)
37. Choussat R, Black AJ, Bossi I, et al. Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents. J Am Coll Cardiol 2000;362:387-395. (Pubitemid 30623997)
38. Schwartz RS, Edelman ER. Drug-eluting stents in preclinical studies. Recommended evaluation from a consensus group. Circulation 2002;106:1867-1873.
39. Nikolaychik V, Sahota H, Keelan Jr MH, et al. Influence of different stent materials on endothelialization in vivo. J Invasive Cardiol 1999;11:410-415.